![]()
Reuters
![]()
Lilly, Incyte rheumatoid arthritis drug succeeds in late-stage studyReutersEli Lilly and Co and Incyte Corp said a third late-stage study of their experimental rheumatoid arthritis drug met its main goal. The drug, baricitinib, was more effective than the decades-old treatment methotrexate, after 24 weeks of treatment, in ...Baricitinib Superior to Methotrexate in Reducing Signs and Symptoms in Pivotal ...MarketWatchall 3 news articles »